MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-19-0009476
Vrnda Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹29.73 Cr
▲ 164% YoY
Net profit · FY 2025
₹1.14 Cr
Net margin 3.8%
EBITDA · FY 2025
₹2.46 Cr
EBITDA margin 8.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹3.32 Cr
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
About Vrnda Pharma Private Limited
Data last updated:
Vrnda Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 August 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2016PTC284291. Its GSTIN is 27AAFCV5566N1ZK (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anjali Santosh Khamkar and Mandar Pramod Bhogle.
Its last annual general meeting (AGM) was held on 24 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 109 1st Floor Kailas Business Park, Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹29.73 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.14 Cr (net margin 3.8%) and EBITDA of ₹2.46 Cr (EBITDA margin 8.3%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years and 33% over five years.
The company is associated with 1 brand: Vrnda Pharma. As per MCA filings, the company has open charges of ₹3.32 Cr on record.
Vrnda Pharma Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-19-0009476). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vrndapharma.com.
Company details
CIN U51909MH2016PTC284291
Registration Number 284291
Incorporation Date 01 August 2016
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 24 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-19-0009476
Recognitions & Rankings of Vrnda Pharma
Contact details
Vrnda Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is vrndapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressUnit No. A – 103 And Unit No. B – 109 1st Floor Kailas Business Park Site Vikhrol, I West, Mumbai, Maharashtra, India – 400079
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Vrnda Pharma Private Limited, buy the company report.
Comprehensive company report
Vrnda Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Vrnda Pharma operates one associated brand: Vrnda Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Supplying active ingredients, pellets, and food supplements for pharmaceutical and food industries in India. | vrndapharma.com |
Business activity
The main business activity of Vrnda Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Vrnda Pharma Private Limited, buy the company report.
Financials of Vrnda Pharma Private Limited
FY 2025 filings availableVrnda Pharma Private Limited reported revenue of ₹29.73 Cr (up 164% YoY) for FY 2025.
Revenue · FY 2025
₹29.73 Cr ▲ 164%
Net profit · FY 2025
₹1.14 Cr margin 3.8%
EBITDA · FY 2025
₹2.46 Cr margin 8.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 164%
3 years · compounded
▲ 33%
5 years · compounded
▲ 33%
EBITDA CAGR growth
1 year
▲ 315%
3 years · compounded
▲ 20%
5 years · compounded
▲ 54%
Revenue has grown at a compounded annual rate (CAGR) of 33% over five years, including 164% growth in the latest year. EBITDA rose 315% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.46 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.14 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.3% | ||||
| Net Profit Margin | 3.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vrnda Pharma Private Limited, buy the company report.
Board of directors of Vrnda Pharma Private Limited
Vrnda Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anjali Santosh Khamkar Also directs: Parn Foundation, Ocevo Private Limited | Director | 01 Aug 2016 | 10 Years 2 Months | Current |
| Mandar Pramod Bhogle Also directs: Parn Foundation | Director | 01 Aug 2016 | 10 Years 2 Months | Current |
Peer comparison
Vrnda Pharma Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Steranco Healthcare Private Limited | ₹29.92 Cr (FY 2025) | 121.0% | Mumbai, Maharashtra, India | |||
| Anekant Pharmaceuticals Private Limited | ₹29.83 Cr (FY 2021) | 54.0% | Delhi, India | |||
| Usan Pharmaceuticals Private Limited | ₹29.79 Cr (FY 2025) | -7.0% | Mumbai, Maharashtra, India | |||
| Nemus Pharmaceuticals Private Limited | ₹29.76 Cr (FY 2025) | 21.0% | Kahalapur, Maharashtra, India | |||
| Vrnda Pharma Private Limitedthis company | ₹29.73 Cr (FY 2025) | ₹1.14 Cr | 3.8% | 164.0% | Mumbai, Maharashtra, India | |
| Cedric Pharmaceuticals Private Limited | ₹29.69 Cr (FY 2025) | 15.0% | Delhi, India | |||
| Infugen Pharma Private Limited | ₹29.66 Cr (FY 2025) | -21.0% | Sangli, Maharashtra, India | |||
| Growmax Medicare Private Limited | ₹29.58 Cr (FY 2025) | 7.0% | New Delhi, Delhi, India | |||
| Maple Cross Remedies Private Limited | ₹29.57 Cr (FY 2024) | -5.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Vrnda Pharma Private Limited, buy the company report.
Auditor
Vrnda Pharma Private Limited is audited by M. A. ANSARI & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M. A. ANSARI & ASSOCIATES | FY 2023 | 135322W |
Shareholding
The shareholding of Vrnda Pharma Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vrnda Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹3.32 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Mar 2024 | 100888777 | Others | ₹35 Lakh | Open | |
| 05 Dec 2022 | 100646228 | Others | ₹56 Lakh | Open | |
| 30 Nov 2022 | 100645464 | Others | ₹62 Lakh | Open | |
| 21 Oct 2022 | 100623072 | Others | ₹95 Lakh | Open | |
| 08 Oct 2018 | 100211270 | Others | ₹50 Lakh | Open |
To see the full charge records of Vrnda Pharma Private Limited, buy the company report.
Total charge records: 6 View all charges
Legal cases
No court or tribunal cases involving Vrnda Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vrnda Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Vrnda Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCV5566N1ZK | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Vrnda Pharma Private Limited, buy the company report.
Recent activity
Vrnda Pharma Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Anjali Santosh Khamkar was appointed as Director on 01 Aug 2016.
AGM
Vrnda Pharma Private Limited last Annual general meeting of members was held on 24 Sep 2025 as per latest MCA records.
Filing
Vrnda Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Others amounted to Rs. 35.00 Lakh with Charge ID 100888777 was registered on 01 Mar 2024.
Charges
A charge with Others of Rs. 95.00 Lakh registered on 21 Oct 2022 with Charge ID 100623072 was modified on 25 Aug 2023.
Charges
A charge with Others amounted to Rs. 56.00 Lakh with Charge ID 100646228 was registered on 05 Dec 2022.
Charges
A charge with Others amounted to Rs. 62.00 Lakh with Charge ID 100645464 was registered on 30 Nov 2022.
Charges
A charge with Others amounted to Rs. 95.00 Lakh with Charge ID 100623072 was registered on 21 Oct 2022.
Charges
A charge with Others amounted to Rs. 50.00 Lakh with Charge ID 100211270 was registered on 08 Oct 2018.
Charges
A charge with Others amounted to Rs. 34.00 Lakh with Charge ID 100130246 was registered on 11 Oct 2017.
Appointed
Anjali Santosh Khamkar was appointed as Director.
Appointed
Mandar Pramod Bhogle was appointed as Director.
Incorporation
01 Aug 2016
Vrnda Pharma Private Limited was registered on 01 Aug 2016 with Roc Mumbai & aged 10 years 2 months as per MCA records.
Frequently asked questions
Vrnda Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 August 2016 (10+ years old) and is registered under CIN U51909MH2016PTC284291.
Vrnda Pharma has 2 current directors:
- Anjali Santosh Khamkar - Director
- Mandar Pramod Bhogle - Director
The latest financial statements of Vrnda Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 24 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Vrnda Pharma is 27AAFCV5566N1ZK, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Vrnda Pharma is U51909MH2016PTC284291. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vrnda Pharma was incorporated on 01 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Vrnda Pharma by revenue are Steranco Healthcare Private Limited, Anekant Pharmaceuticals Private Limited, Usan Pharmaceuticals Private Limited, Nemus Pharmaceuticals Private Limited, Cedric Pharmaceuticals Private Limited and 3 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Anjali Santosh Khamkar was appointed as Director on 01 Aug 2016. Mandar Pramod Bhogle was appointed as Director on 01 Aug 2016.
Yes, Vrnda Pharma is registered as an MSME under Udyam registration (number: UDYAM-MH-19-0009476).
Vrnda Pharma can be reached through the website vrndapharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Vrnda Pharma is at Unit No. A – 103 And Unit No. B – 109 1st Floor Kailas Business Park Site Vikhrol, I West, Mumbai, Maharashtra, India – 400079.